| Aug 6 |
Omega Therapeutics GAAP EPS of -$0.30, revenue of $2.13M
|
| Aug 6 |
Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 6 |
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
|
| Aug 6 |
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
|
| Jun 24 |
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
|
| Jun 19 |
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
|
| Jun 18 |
Raymond James starts Omega at outperform, cites platform
|
| May 30 |
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
|
| May 29 |
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
|
